Avion Wealth’s Rein Therapeutics RNTX Stock Holding History

Avion Wealth’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	–	–	1684
2025 Q1	$0	Buy	+200	New	+$420	﹤0.01%	1406
2024 Q4	–	Sell	-200	Closed	–	–	1320
2024 Q3	$0	Buy	+200	New	+$535	﹤0.01%	1381

Other funds holding RNTX

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Avion Wealth's RNTX Position: Q2 2025 in Review

Avion Wealth sold out of Rein Therapeutics (RNTX) in Q2 2025, closing a stake of 200 shares.

Avion Wealth first reported a position in RNTX in Q3 2024 and held it in 2 quarters. The position peaked at $0 in Q1 2025. 36 funds tracked by Wall St. Rank hold RNTX as of Q2 2025.

Avion Wealth reported no remaining Rein Therapeutics position as of Q2 2025 after selling out during the quarter.
Avion Wealth sold 200 Rein Therapeutics shares in Q2 2025.
Avion Wealth first reported a position in Rein Therapeutics in Q3 2024 and held it in 2 quarters.
Avion Wealth's Rein Therapeutics position peaked at $0 in Q1 2025.
36 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2025.

Based on Avion Wealth's 13F filing for Q2 2025, filed 25 Jul 2025.